BNP Paribas Financial Markets’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54K Sell
1,183
-6,902
-85% -$9.51K ﹤0.01% 5559
2026
Q1
$10.4K Sell
8,085
-803
-9% -$1.33K ﹤0.01% 5212
2025
Q4
$19.6K Buy
8,888
+794
+10% +$1.49K ﹤0.01% 5026
2025
Q3
$13.1K Buy
8,094
+3,555
+78% +$7.44K ﹤0.01% 4972
2025
Q2
$11.8K Buy
4,539
+841
+23% +$3.32K ﹤0.01% 4806
2025
Q1
$24.9K Sell
3,698
-2,567
-41% -$18.2K ﹤0.01% 4471
2024
Q4
$42.5K Buy
+6,265
New +$41.3K ﹤0.01% 4488

Other funds holding LUNG

BNP Paribas Financial Markets's LUNG Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Pulmonx (LUNG) stake by 85% in Q2 2026, selling an estimated $9.51K and leaving 1,183 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #5559.

BNP Paribas Financial Markets first reported a position in LUNG in Q4 2024 and has held it in 7 quarters since. The position peaked at $42.5K in Q4 2024. 98 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • BNP Paribas Financial Markets held 1,183 shares of Pulmonx worth $1.54K as of Q2 2026.
  • BNP Paribas Financial Markets sold 6,902 Pulmonx shares in Q2 2026, an estimated $9.51K.
  • Pulmonx made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5559 holding.
  • BNP Paribas Financial Markets first reported a position in Pulmonx in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Pulmonx position peaked at $42.5K in Q4 2024.
  • 98 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.